Fifty-eight biopharmaceuticals were approved by the US and the EU from January 2006 to June 2010. These include 30 hormones, growth factors and other regulatory molecules; 13 mAb-based products; four blood-related proteins; two subunit vaccines; and nine other biopharmaceuticals, including fusion proteins and therapeutic enzymes. Twenty-five of these products were new biopharmaceuticals, as opposed to […]
When the US stimulus ends September 30, academic research could suffer. The NIH has funded 18,568 biomedical research projects with the $8.2 billion it received over two years from the stimulus. Its annual grant and contract budget could drop by about 15%, going by this year’s appropriation of $26.2 billion. Universities that have received the […]
Second-quarter 2010 IBO Life Science Index sales improved 8.3% to $2,835.24 million, including a loss of 0.2% from currency. Operating profit jumped 20.0% to $647.97 million, and operating margin climbed 230 basis points to 22.9% of sales. Second-quarter sales for Beckman Coulter’s Life Science segment declined 2.1%, 3.2% excluding currency, to $106.5 million (see page […]
A new nationwide research initiative, launched by the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health (NIH), hopes to improve vaccines and therapeutics. The NIH will allocate $100 million over five years to conduct the research at six Human Immune Phenotyping Centers—Baylor Research Institute, Dana-Farber Cancer Institute, Emory […]
Rockville, MD and Seoul, South Korea 9/13/11—Seegene has raised $16.6 million through an offering of 636,500 shares on the KOSDAQ, the Korean Stock Exchange. Seegene provides PCR technology for molecular diagnostics and research applications. “Our products are defining a new category of molecular diagnostics that are capable of simultaneously detecting multiple pathogens or genetic mutations […]
Copenhagen, Denmark 8/23/10—FOSS A/S has increased its holdings in Ibsen Photonics from 12.5% to 85%. Ibsen Photonics provides holographic, fused silica transmission gratings and spectrometer modules for a wide range of telecom, analytical, sensing and laser markets. “We have worked with Ibsen for some years now and have found their spectrometer solutions to be second […]
Orange County, CA 9/7/10—Beckman Coulter Chairman, President and CEO Scott Garrett has resigned, effective September 6. He will continue as a full-time nonexecutive employee through January 15, 2011. The Board has named J. Robert Hurley interim president and CEO. He has served as senior vice president, Human Resources, and chairman of Beckman Coulter Japan. He […]
West Chester, PA 9/2/10—VWR International has announced the acquisition of LABART SP. ZOO, a distributor of scientific laboratory supplies that is headquartered in Gdansk, Poland. Founded in 1996, LABART provides lab equipment and consumables to the industrial, pharmaceutical, tertiary scientific education and public sectors.
Billerica, MA 9/3/10; Washington, DC 9/3/10—Bruker Energy & Supercon Technologies (BEST), a subsidiary of Bruker, has filed an S-1 registration statement with the SEC for an IPO. Following the stock offering, Bruker will retain a controlling stake. BEST develops, manufactures and markets superconducting materials, ceramic high-temperature superconductors, non-superconducting Cuponal materials and wires, and devices, such […]
Glenview, IL 9/2/10; London, UK 9/3/10—Private equity firm 3i has agreed to sell Panreac, a Spanish manufacturer and supplier of chemicals for lab research and production, to industrial conglomerate Illinois Tool Works (ITW). Panreac’s portfolio is comprised of 12,000 products, including reagents, high-purity solvents for HPLC, and fine chemicals. Based in Barcelona, the company has […]
Pay Invoice
Latest Blogs
-
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
October 24, 2024 5:17 pm
-
M&A Activity in the Analytical Instrumentation and Lab Tools Market. 2021-2023
September 30, 2024 1:32 pm
-
Survey Results: Life Science Labs and Sustainable Consumables
August 30, 2024 7:43 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
